HYDROFLUMETHIAZIDE; RESERPINE - Generic Drug Details

What are the generic sources for hydroflumethiazide; reserpine and what is the scope of patent protection?

Hydroflumethiazide; reserpine is the generic ingredient in four branded drugs marketed by Usl Pharma, Watson Labs, Ivax Pharms, Par Pharm, and Shire, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

Summary for HYDROFLUMETHIAZIDE; RESERPINE

US Patents:	0
Tradenames:	4
Applicants:	5
NDAs:	6
DailyMed Link:	HYDROFLUMETHIAZIDE; RESERPINE at DailyMed

Anatomical Therapeutic Chemical (ATC) Classes for HYDROFLUMETHIAZIDE; RESERPINE

C02AA	Rauwolfia alkaloids
C02A	ANTIADRENERGIC AGENTS, CENTRALLY ACTING
C02	ANTIHYPERTENSIVES
C	Cardiovascular system

C03AA	Thiazides, plain
C03A	LOW-CEILING DIURETICS, THIAZIDES
C03	DIURETICS
C	Cardiovascular system

US Patents and Regulatory Information for HYDROFLUMETHIAZIDE; RESERPINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Shire	SALUTENSIN	hydroflumethiazide; reserpine	TABLET;ORAL	012359-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Watson Labs	HYDROFLUMETHIAZIDE AND RESERPINE	hydroflumethiazide; reserpine	TABLET;ORAL	088127-001	Mar 22, 1983		DISCN	No	No
Watson Labs	HYDROFLUMETHIAZIDE AND RESERPINE	hydroflumethiazide; reserpine	TABLET;ORAL	088110-001	Mar 22, 1983		DISCN	No	No
Ivax Pharms	RESERPINE AND HYDROFLUMETHIAZIDE	hydroflumethiazide; reserpine	TABLET;ORAL	088932-001	Jan 11, 1985		DISCN	No	No
Usl Pharma	HYDROFLUMETHIAZIDE AND RESERPINE	hydroflumethiazide; reserpine	TABLET;ORAL	088195-001	Oct 26, 1983		DISCN	No	No
Shire	SALUTENSIN-DEMI	hydroflumethiazide; reserpine	TABLET;ORAL	012359-004	Approved Prior to Jan 1, 1982		DISCN	No	No
Par Pharm	RESERPINE AND HYDROFLUMETHIAZIDE	hydroflumethiazide; reserpine	TABLET;ORAL	088907-001	Sep 20, 1985		DISCN	No	No